Fri, May 7, 2021

Geoff Meacham Upgraded (YMAB) to Strong Buy and Held Target at $56 on, May 7th, 2021

Geoff Meacham of B of A Securities, Upgraded "Y-mAbs Therapeutics, Inc." (YMAB) to Strong Buy and Held Target at $56 on, May 7th, 2021.

Geoff has made no other calls on YMAB in the last 4 months.



There are 2 other peers that have a rating on YMAB. Out of the 2 peers that are also analyzing YMAB, 0 agree with Geoff's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoff


  • Tessa Romero of "JP Morgan" Initiated at Buy and Held Target at $52 on, Monday, March 22nd, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $70 on, Monday, March 1st, 2021